Key facts
- What it is: a mucin-degrading commensal that lives in the gut mucus layer.
- On the GI-MAP: quantified as a beneficial/keystone-flora marker.
- Why it matters: studied in relation to gut-barrier and metabolic health.
- Method: quantitative PCR (qPCR).
Akkermansia muciniphila lives in the gut's mucus layer, where it helps regulate mucus turnover and the integrity of the gut barrier. It has become one of the most studied “keystone” commensals, and the GI-MAP (Gastrointestinal Microbial Assay Plus) quantifies it among the beneficial flora.
What the research shows
In mechanistic studies, Akkermansia muciniphila influenced the gut barrier and metabolic markers — for example, controlling aspects of diet-induced obesity in mice (PMID: 23671105). Much of the strongest evidence to date is from animal and mechanistic work, so human clinical significance is still an active area of study.
Because of this, an Akkermansia level on the GI-MAP is best read as part of the overall beneficial-flora picture rather than a stand-alone verdict.
Interpreting your level
A healthy amount of Akkermansia is generally considered favourable for the gut barrier, while a very low level may accompany dysbiosis. As with all GI-MAP markers, the number is interpreted with your symptoms and the rest of the panel by a qualified practitioner and does not diagnose disease.
The GI-MAP™ reports this and 85+ other markers from one at-home sample.
Order Your GI-MAP™ Test → See pricingReferences
- Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and the intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110(22):9066–9071. PMID: 23671105.